The 4th GPCR-Targeted Drug Discovery Summit focuses on strategies for advancing GPCR-targeted drug discovery, including the use of advanced technology, ensuring drug selectivity, and expanding druggable GPCR targets.
Topics
How to employ advanced technology to streamline hit-to-lead generation of small molecules and biologics?
What is the GPCR commercial and investor opportunity?
How to ensure selectivity and potency of GPCRs-targeted drugs?
How to characterize the complex dynamic confirmations of GPCRs?
How to fast-track IND-filing & accelerate the progression of novel small molecule and biologic candidates into the clinic?
How can we comprehensively expand the repertoire of druggable GPCRs targets, including orphan GPCRs?
